Efficacy and safety of low‐dose sacubitril/valsartan in heart failure patients: A systematic review and meta‐analysis

BACKGROUND: Controversy has persisted over the clinical benefits of low‐dose sacubitril/valsartan in patients with heart failure (HF). HYPOTHESIS: Low‐dose sacubitril/valsartan might also be effective and safe in HF patients. METHODS: Electronic databases including PubMed, Ovid, and Cochrane Library...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen‐Wen, Jiang, Juan, Gao, Jie, Zhang, Xiu‐Zhen, Li, Yuan‐Min, Liu, Yan‐Lin, Dang, He‐Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018087/
https://www.ncbi.nlm.nih.gov/pubmed/36648084
http://dx.doi.org/10.1002/clc.23971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018087/
https://www.ncbi.nlm.nih.gov/pubmed/36648084
http://dx.doi.org/10.1002/clc.23971

Ejemplares similares